BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22416048)

  • 21. Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase.
    Achari A; Somers DO; Champness JN; Bryant PK; Rosemond J; Stammers DK
    Nat Struct Biol; 1997 Jun; 4(6):490-7. PubMed ID: 9187658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bisubstrate analogue inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: New design with improved properties.
    Shi G; Shaw G; Liang YH; Subburaman P; Li Y; Wu Y; Yan H; Ji X
    Bioorg Med Chem; 2012 Jan; 20(1):47-57. PubMed ID: 22169600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of molecular docking programs for virtual screening against dihydropteroate synthase.
    Hevener KE; Zhao W; Ball DM; Babaoglu K; Qi J; White SW; Lee RE
    J Chem Inf Model; 2009 Feb; 49(2):444-60. PubMed ID: 19434845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors.
    Capasso C; Supuran CT
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):379-87. PubMed ID: 23627736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational insights into factor affecting the potency of diaryl sulfone analogs as Escherichia coli dihydropteroate synthase inhibitors.
    Das BK; Pv P; Chakraborty D
    Comput Biol Chem; 2019 Feb; 78():37-52. PubMed ID: 30497019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Class-Specific Monoclonal Antibodies and Dihydropteroate Synthase in Bioassays Used for the Detection of Sulfonamides: Structural Insights into Recognition Diversity.
    Li C; Liang X; Wen K; Li Y; Zhang X; Ma M; Yu X; Yu W; Shen J; Wang Z
    Anal Chem; 2019 Feb; 91(3):2392-2400. PubMed ID: 30580515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hybrid-drug design targeting Pseudomonas aeruginosa dihydropteroate synthase and dihydrofolate reductase.
    Jayaraman P; Sakharkar KR; Daniel LC; Siddiqi MI; Dhillon SK; Sakharkar MK
    Front Biosci (Elite Ed); 2013 Jun; 5(3):864-82. PubMed ID: 23747902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of new series of 1-Aryl-1,4-dihydro-4-oxo-6-methyl pyridazine-3-carboxylic acid as potential antibacterial agents.
    Nagawade RR; Khanna VV; Bhagwat SS; Shinde DB
    Eur J Med Chem; 2005 Dec; 40(12):1325-30. PubMed ID: 16126308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel and potent inhibitors for dihydropteroate synthase of
    Satuluri SH; Katari SK; Pasala C; Amineni U
    J Recept Signal Transduct Res; 2020 Jun; 40(3):246-256. PubMed ID: 32098568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of pyrazolo-1,2,4-triazolo[4,3-a]quinoxalines as antimicrobial agents with potential inhibition of DHPS enzyme.
    Z El-Attar MA; Elbayaa RY; Shaaban OG; Habib NS; Abdel Wahab AE; Abdelwahab IA; M El-Hawash SA
    Future Med Chem; 2018 Sep; 10(18):2155-2175. PubMed ID: 30088415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elucidation of sulfadoxine resistance with structural models of the bifunctional Plasmodium falciparum dihydropterin pyrophosphokinase-dihydropteroate synthase.
    de Beer TA; Louw AI; Joubert F
    Bioorg Med Chem; 2006 Jul; 14(13):4433-43. PubMed ID: 16517168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety.
    Nasr T; Bondock S; Eid S
    Eur J Med Chem; 2014 Sep; 84():491-504. PubMed ID: 25050881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of the 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase•dihydropteroate synthase bifunctional enzyme from Francisella tularensis.
    Pemble CW; Mehta PK; Mehra S; Li Z; Nourse A; Lee RE; White SW
    PLoS One; 2010 Nov; 5(11):e14165. PubMed ID: 21152407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, Synthesis, Antimicrobial Evaluation and in Silico Studies of Eugenol-Sulfonamide Hybrids.
    Azevedo-Barbosa H; do Vale BP; Guidolin Rossi G; Dos Santos Siqueira F; Bordignon Guterres K; de Campos MMA; Dos Santos T; Anthony Hawkes J; Ferreira Dias D; Neiva Lavorato S; de Souza TB; Teixeira Carvalho D
    Chem Biodivers; 2021 May; 18(5):e2100066. PubMed ID: 33829648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of dihydropteroate synthase: substituent effects in the side-chain aromatic ring of 6-[[3-(aryloxy)propyl]amino]-5-nitrosoisocytosines and synthesis and inhibitory potency of bridged 5-nitrosoisocytosine-p-aminobenzoic acid analogues.
    Lever OW; Bell LN; Hyman C; McGuire HM; Ferone R
    J Med Chem; 1986 May; 29(5):665-70. PubMed ID: 3486292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bisubstrate inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: Transition state analogs for high affinity binding.
    Shi G; Shaw GX; Zhu F; Tarasov SG; Ji X
    Bioorg Med Chem; 2021 Jan; 29():115847. PubMed ID: 33199204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacophore requirements in new series of pyridazinyl alkanoic acids, N-[(pyridazin-2-yl) alkyl] succinyl and glutaryl amides, inhibitors of thromboxane A2 biosynthesis.
    Moreau S; Coudert P; Lasserre B; Vallée-Goyet D; Gardette D; Navarro-Delmasure C; Pham Huu Chanh A; Dossou-Gbete V; Couquelet J
    Prostaglandins Leukot Essent Fatty Acids; 1997 Jun; 56(6):431-6. PubMed ID: 9223653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural characterization of new Schiff bases of sulfamethoxazole and sulfathiazole, their antibacterial activity and docking computation with DHPS protein structure.
    Mondal S; Mandal SM; Mondal TK; Sinha C
    Spectrochim Acta A Mol Biomol Spectrosc; 2015; 150():268-79. PubMed ID: 26056977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. QSAR analysis of antibacterial activity of some 4-aminodiphenylsulfone derivatives.
    Agrawal VK; Bano S; Khadikar PV
    Acta Microbiol Immunol Hung; 2003; 50(4):385-93. PubMed ID: 14750439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of piperazic acid peptide deformylase inhibitors with in vivo activity for respiratory tract and skin infections.
    Spletstoser JT; Dreabit J; Knox AN; Benowitz A; Campobasso N; Ward P; Cui G; Lewandowski T; McCloskey L; Aubart KM
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2410-2414. PubMed ID: 31160176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.